UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Presentation Slides from the 4th Partnerships in Biocontrol, Biostimulants & Microbiome Congress: USA

At the recent 4th Partnerships in Biocontrol, Biostimulants & Microbiome Congress: USA we heard a number of interesting presentations on how plant and soil microbiome research is identifying microbes to enhance crop productivity and disease resistance.

Thanks to some of our speakers, we have made the following slides discussing the current regulatory landscape from Sarah Caffery, Keith Matthews, and Terry Stone available to view.

Read More

The Future is Bright for Probiotics

I am extremely sceptical of all claims about probiotics. For the last 10 years of running Probiotics.org, companies have been sending me questionable products with extraordinarily impossible to believe claims.

But, after Global Engage’s 4th Probiotic & Prebiotics Congress, here’s what I strongly believe:

Read More

Presentation Slides from the 7th Plant Genomics & Gene Editing Congress: USA

The recent 7th Plant Genomics Congress: USA provided a fantastic opportunity to discover how novel gene-editing technologies, CRISPR and other ‘omics’ technologies are being applied to research and product development. We have made the following slides from Jerry Feitelson, Lynne Reuber, Greg Bryan and Chloe Pavely available to view.

Read More

3 Ways Single-Cell Sequencing and AI are Transforming Kidney Transplantation

Transplantation is now a successful therapy for end-stage renal disease (ESRD). The first successful kidney transplantation happened in Boston in 1954 and the procedure is now routine clinical practice in more than 80 countries worldwide.

Ishita Moghe and Kim Solez outline some of the major strides taken in kidney pathology and transplantation through the use of scRNA-seq and Artificial Intelligence (AI). 

Read More

Slides from the 4th Medicinal Chemistry & Protein Degradation Summit

The 4th Medicinal Chemistry & Protein Degradation Summit provided two days of fascinating topics and case studies about AI-assisted lead optimisation, DNA encoded libraries and the use of data and informatics in drug-discovery. We have made the following presentation slides available from Greg Makara, Paul Colbon and Yugal Sharma.

Read More

Even with genetic modification, resistance may be a nasty problem

Natural resistance to our methods to control pests and weeds is a brand new phenomenon, historically speaking. It only evolved as mankind started to use chemical, and later biotechnological means to control nature. Genetic modification may not be the answer to resistance. Attempts to control pests and weeds by growing GM plants run into the same problem as the application of chemical agents. But still, nature may provide some answers.

Read More

Digital Pathology Solutions for low-budget and low-tech regions of the world

Digital pathology is transforming possibilities for patient care and the nature of pathologists’ work. But it is clear that in low-income countries, access to pathology and laboratory medicine (PALM) services is very restricted and under-developed.[1] Low-income countries bear a disproportionate share of the global disease burden, yet they are so under-resourced in the pathology and laboratory services that are vital for the accurate diagnosis and treatment of disease.[2] This presents a huge issue for global health.

Given this global context, Rebecca Calder, Daniel Stevens and Zev Leifer’s poster, presented at the 5th Digital Pathology and AI Congress, is of notable significance.

Read More

Diverse Approaches in Immuno-Oncology: A Review of the Research & Technology Series

This blog was published on Clarivate’s Cortellis blog. It is reproduced here with their kind permission.

A fascinating range of insights into the ways in which the immune system can be harnessed to fight cancer was provided by Global Engage’s Immuno-Oncology Research & Technology Series meeting held in October in London. The conference comprised five concurrent tracks covering cutting-edge developments in fields such as cell therapies, novel antibodies and neoantigens. Some of the highlights tracked by the Cortellis team are presented below.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive